Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
Clinical trial NCT00670358 · COMPLETED
Trial details
- NCT number
- NCT00670358
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-25
- Primary completion
- 2021-05-07
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.